Jordi Llinares-Garcia

Jordi Llinares is the head or orphan medicines at the European Medicines Agency (EMA).

He is responsible for the group assessing applications for orphan designation and coordinates the activities necessary for the adoption of opinions on orphan designation, including the drafting of summary reports and supports the secretariat of the Committee for Orphan Medicinal Products (COMP).

Dr. Llinares joined the EMA in 2002. Prior to joining the EMA, Dr Llinares worked as clinical pharmacologist at Hospital de Sant Pau (Barcelona) and collaborated with the Spanish Drugs Agency as clinical assessor. Dr Llinares was a member of the Ethics Committee of the Institut d’Assistencia Sanitaria (Salt).

Dr. Llinares graduated as an MD from the University of Barcelona and specialised (MIR) as clinical pharmacologist at Hospital Vall d’Hebron (Barcelona). Dr Llinares holds a Masters in Science in Epidemiology from the London School of Hygiene and Tropical Medicine (London).

www.ema.europa.eu

 
 
A voz das pessoas com doenças raras na EuropaEURORDIS A voz internacional das pessoas com doenças raras, Rare Diseases InternacionalRare Disease International Reúne doentes, famílias e especialistas para partilhar experiências num fórum multilinguístico. RareConnect O programa Rare Barometer é uma iniciativa da EURORDIS para a realização de inquéritos para transformar a experiência das pessoas com doenças raras em números e factos que podem ser partilhados com os responsáveis pela tomada de decisões.Rare Barometer An international awareness raising campaign taking place on the last day of February each year, Rare Disease Day is a EURORDIS initiativeRare Disease Day Adira ao maior encontro europeu das partes interessadas no âmbito das doenças raras na Conferência Bienal Europeia sobre Doenças Raras e Produtos Órfãos. A ECRD é uma iniciativa da EURORDISEuropean Conference on Rare Diseases